Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Molndal – page 8

466 clinical trials in Molndal, Sweden across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Molndal at a glance
466
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

466 trials in Molndal

Open in trial search

Neuroblastoma

Recruiting

Study of Temozolomide, Topotecan, Bevacizumab, Irinotecan and Dinutuximab Beta in Patients with High-Risk Relapsed Neuroblastoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Bevacizumab
  • Sponsor:The University Of Birmingham

Prostate cancer

Recruiting

Study on Darolutamide for Patients with High-Risk Localized or Locally Advanced Prostate Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Karolinska University Hospital

Osteoarthritis

Recruiting

Study on Treating Knee Osteoarthritis with Nasal Cartilage Implantation for Patients with Patellofemoral Osteoarthritis

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:N-Tec
  • Sponsor:Universitaetsspital Basel

Study on Tick-Borne Encephalitis: Evaluating T-Cell Responses Using Cytokine Release Assay in Healthy and Immunosuppressed Patients with TBE Vaccines

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Tick-borne encephalitis virus neudoerfl strain adsorbed on aluminium hydroxide, hydrated produced in chick embryo cells
  • Sponsor:Vastra Gotalandsregionen

Measles

Recruiting

Study on Immunity to Measles and Chickenpox in Children with Cancer Using Measles, Mumps, Rubella, and Varicella Vaccines

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · Healthy volunteers
  • Substances:Measles virus edmonston-schwarz strain (live, attenuated) produced in chick embryo cells
  • Sponsor:Vastra Gotalandsregionen

Study of Rituximab versus Placebo to Improve Lung Function in Patients with Granulomatous Lymphocytic Interstitial Lung Disease (GLILD)

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Oslo University Hospital HF

Hepatoblastoma+1

Recruiting

Study on the Safety and Effectiveness of Patritumab Deruxtecan for Children with Relapsed or Refractory Hepatoblastoma and Rhabdomyosarcoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Dexamethasone
  • Sponsor:Merck Sharp & Dohme LLC

Comparison of TAK-881 and HyQvia for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:Takeda Development Center Americas Inc.

Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Study Comparing Ipilimumab and Nivolumab to Nivolumab Alone for Patients with Resectable Stage III Melanoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Karolinska University Hospital

Study on the Safety and Effectiveness of Emicizumab for Patients with TYPE 3 Von Willebrand Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Efmoroctocog Alfa
  • Sponsor:F. Hoffmann-La Roche AG

Study on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Molndal

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on heart failure prevention and treatment, including studies of new combination therapies with medications like baxdrostat and dapagliflozin. Research extends to coronary artery disease and stroke prevention in patients with atrial fibrillation.

  • Heart Failure Management
  • Stroke Prevention
  • Coronary Disease Treatment
02 Neurological Studies

Groundbreaking research in Alzheimer's disease treatment, investigating new compounds for early-stage intervention. Studies aim to improve cognitive function and evaluate novel therapeutic approaches for mild cognitive impairment.

  • Early Alzheimer's Treatment
  • Cognitive Function Assessment
  • Disease Progression Monitoring
03 Dermatological Research

Advanced trials examining treatments for atopic dermatitis and alopecia areata, testing new biological therapies and investigating long-term treatment efficacy and safety profiles.

  • Moderate-to-Severe Atopic Dermatitis
  • Alopecia Treatment
  • Skin Disease Management
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.